EE2 Health Outcome in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma Treated With First-Line Sintilimab Plus Cisplatin and Paclitaxel Versus Cisplatin and Paclitaxel
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.257
https://www.valueinhealthjournal.com/article/S1098-3015(22)02461-5/fulltext
Section Title :
Section Order :
12062
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02461-5&doi=10.1016/j.jval.2022.09.257